PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 17, 2009Hypertension58 citationsOpen Access

Antihypertensive Prescriptions for Newly Treated Patients Before and After the Main Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Results and Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure Guidelines

View Full Paper
PMPaul MuntnerMKMarie Krousel‐WoodAHAmanda D. Hyre

Structured PICO

Did the publication of the ALLHAT trial results and JNC 7 guidelines increase the prescription of thiazide-type diuretics as initial therapy for hypertension?

P
Population
4,761 patients initiating pharmacological antihypertensive treatment in a large managed care organization across 3 time periods (n=1354 in 2001-2002; n=1542 in 2003-2004; n=1865 in 2004-2005).
I
Intervention
Time periods after the publication of ALLHAT trial results and JNC 7 guidelines (July 2003-June 2004 and July 2004-June 2005).
C
Comparator
Time period before the publications (July 2001-June 2002).
O
Outcome
Percentage of patients initiating antihypertensive treatment with a thiazide-type diuretic.

The publication of the ALLHAT trial and JNC 7 guidelines was associated with a significant but modest and sustained increase in the initiation of thiazide-type diuretics for hypertension.

Abstract

Main results of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial were published in December 2002. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, published in May 2003, recommended thiazide-type diuretics as initial pharmacological treatment alone or in combination with another drug in most patients with hypertension. To assess changes from before to after these publications, we compared antihypertensive medication prescriptions filled by patients who initiated pharmacological antihypertensive treatment in a large managed care organization during 3 time periods: (1) July 1, 2001, to June 30, 2002 (before these publications; n=1354); (2) July 1, 2003, to June 30, 2004 (to assess short-term changes; n=1542); and (3) July 1, 2004, to June 30, 2005 (to assess extended changes; n=1865). The percentage of patients initiating antihypertensive treatment with a thiazide-type diuretic increased from 30.6% to 39.4% (P<0.001) between 2001-2002 and 2003-2004, and the increase was maintained at 36.5% in 2004-2005 (P<0.001 compared with 2001-2002 and P=0.33 compared with 2003-2004). Among patients without diabetes mellitus, renal disease, a history of myocardial infarction, or heart failure, the percentage initiating pharmacological antihypertensive treatment with a thiazide-type diuretic increased from 33.1% in 2001-2002 to 43.4% in 2003-2004 (P<0.001) and remained increased (41.0%) in 2004-2005 (P<0.001 and P=0.23 compared with 2001-2002 and 2003-2004, respectively). Despite a sustained increase in the use of thiazide-type diuretics, this study indicates that an opportunity exists to increase adherence to the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure guidelines.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Muntner et al. (2009) studied this question.

synapsesocial.com/papers/6a8262245a62cdcac13f1bdahttps://doi.org/10.1161/hypertensionaha.108.120154
Ask AI
Helpful
Bookmark
Share
View Full Paper